Correlation of dose with toxicity and tumour response to (90)Y- and (177)Lu-PRRT provides the basis for optimization through individualized treatment planning

PURPOSE: Peptide receptor radionuclide therapy (PRRT) with (90)Y-labelled and (177)Lu-labelled peptides is an effective strategy for the treatment of metastatic/nonresectable neuroendocrine tumours (NETs). Dosimetry provides important information useful for optimizing PRRT with individualized regime...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Nucl Med Mol Imaging
Main Authors: Cremonesi, Marta, Ferrari, Mahila Esmeralda, Bodei, Lisa, Chiesa, Carlo, Sarnelli, Anna, Garibaldi, Cristina, Pacilio, Massimiliano, Strigari, Lidia, Summers, Paul Eugene, Orecchia, Roberto, Grana, Chiara Maria, Botta, Francesca
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6716520/
https://ncbi.nlm.nih.gov/pubmed/29785514
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-018-4044-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados